Q2 2019 Holdings
Filed 2019-08-14 | 197 holdings | $207.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $52.5M | 224,690 | 25.4% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $27.2M | 632,250 | 13.1% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $24.2M | 333,316 | 11.7% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $21.1M | 245,763 | 10.2% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $11.8M | 94,889 | 5.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $11.7M | 161,372 | 5.7% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $8.5M | 73,647 | 4.1% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $7.7M | 28,278 | 3.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $7.3M | 145,342 | 3.5% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $6.4M | 291,419 | 3.1% |
| Acadia Healthcare Co., Inc.(ACHC) | Common | 00404A109 | $6.1M | 173,155 | 2.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $4.3M | 160,147 | 2.1% |
| Bausch Health Co. Inc.(BHC) | Common | 071734107 | $4.3M | 168,812 | 2.1% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $4.0M | 28,381 | 1.9% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $2.0M | 14,167 | 1.0% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $1.7M | 639,370 | 0.8% |
| Cellectis SA(CLLS) | Sponsored ADR | 15117K103 | $1.7M | 110,147 | 0.8% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $919.0K | 228,496 | 0.4% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $814.0K | 30,700 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $545.0K | 203,935 | 0.3% |
| Celgene Corp.(CELG) | Common | 151020104 | $136.2K | 1,473,710 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $134.5K | 729,658 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $124.0K | 1,836,112 | 0.1% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $124.0K | 890,004 | 0.1% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $89.8K | 489,734 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $89.6K | 2,068,265 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $85.0K | 1,013,695 | 0.0% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $79.1K | 324,133 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $73.1K | 198,471 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $52.4K | 400,014 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $52.3K | 166,968 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $46.8K | 480,035 | 0.0% |
| Incyte Corp.(INCY) | Common | 45337C102 | $43.4K | 510,933 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $42.4K | 504,148 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $40.0K | 136,198 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $33.5K | 738,044 | 0.0% |
| CVS Health Corp.(CVS) | Common | 126650100 | $31.4K | 575,401 | 0.0% |
| Intuitive Surgical, Inc.(ISRG) | Common | 46120E602 | $29.2K | 55,675 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $29.2K | 103,456 | 0.0% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $28.2K | 248,584 | 0.0% |
| Eli Lilly and Co.(LLY) | Common | 532457108 | $28.1K | 253,199 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $25.3K | 277,047 | 0.0% |
| Allergan plc | Shares | G0177J108 | $24.2K | 144,281 | 0.0% |
| Danaher Corp.(DHR) | Common | 235851102 | $22.7K | 158,931 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $22.5K | 147,847 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $21.2K | 102,950 | 0.0% |
| Seattle Genetics, Inc. | Common | 812578102 | $20.1K | 289,925 | 0.0% |
| Celldex Therapeutics, Inc.(CLDX) | Common | 15117B202 | $19.0K | 7,053 | 0.0% |
| Cigna Corporation(CI) | Common | 125523100 | $18.4K | 116,756 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $18.0K | 943,152 | 0.0% |